Future Trends of Human Insulin Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Future Trends of Human Insulin Market

Description:

The global human insulin market crossed $23 billion in 2013 and is poised to grow at a high double-digit CAGR from 2014 to 2019. – PowerPoint PPT presentation

Number of Views:31

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Future Trends of Human Insulin Market


1
MarketsandMarkets Presents
Human Insulin Market worth 42 Billion by 2019
2
  • The Human Insulin Market by Product Type Human
    Insulin (Short Acting, Intermediate Acting,
    Premixed), Modern Human Insulin (Rapid Acting,
    Long Acting, Premixed), by Brand (Lantus,
    Apidra, Levemir, NovoRapid, Novomix, Tresiba,
    Others) - Forecast to 2019provides a detailed
    overview of the major drivers,restraints,
    challenges, opportunities, current market
    trends,and strategies impacting the global human
    insulin market along with the estimates and
    forecasts of the revenue and share analysis.
  • Browse 110 market data tables and 55 figures
    spread through 232 pages and in-depth TOC on
    "Human Insulin Market by Product Type Human
    Insulin (Short Acting, Intermediate Acting,
    Premixed), Modern Human Insulin (Rapid Acting,
    Long Acting, Premixed), by Brand (Lantus,
    Apidra, Levemir, NovoRapid, Novomix, Tresiba,
    Others) - Forecast to 2019"
  • http//www.marketsandmarkets.com/Market-Reports/hu
    man-insulin-market-229295783.html

3

Early buyers will receive 10 customization on
Reports.
4
  • The global human insulin market crossed 23
    billion in 2013 and is poised to grow at a high
    double-digit CAGR from 2014 to 2019.
  • The market is segmented based on products, and
    types of insulin. Based on products, the global
    human insulin market is segmented into biologics
    and biobetters, and biosimilars/biogenerics.
    Human insulin market is also segmented into
    traditional and modern human insulin. Of these,
    modern human insulin and biosimilarswill be the
    fastest-growing market in the next five years.The
    major factors propelling this growth are cost
    effective treatment offered while using modern
    human insulin and low price of biosimilars/biogene
    ric drugs of human insulin thereby stimulating
    the demand for biosimilar human insulin products.
  • By type of insulin, traditional human insulin is
    further segmented into short acting human
    insulin, intermediate acting human insulin, and
    premixed whereas Modern human insulin is
    fragmented into long acting human insulin, rapid
    acting human insulin, and premixed modern human
    insulin. Of all, long acting human insulin
    accounted for the largest share and pre-mixed
    human insulin will be the fastest growing market
    witnessing double-digit growth between 2014-2019.

5
  • Geographic analysis reveals that North America is
    the largest contributor to the global human
    insulin market in 2014 and will witness moderate
    growth between 2014-2019.
  • Asia-Pacific will be the fastest growing market
    for human insulin production, development, and
    distribution. Further, Asia-Pacific countries are
    considered to be the lucrative ones for investors
    to invest in for manufacturing and clinical
    activities of pipeline and existing human insulin
    product. Major players enter the Asian market
    with the purpose to collaborate with various CMO
    and CRO existing in this region that fosters the
    development of human insulin at lower cost
    compared to the other region across the globe.
    The demand for human insulin will be on the rise
    in coming five years due to the high prevalence
    rate of diabetes as well as low price of human
    insulin.
  • The key players in the market are Novo Nordisk
    (Denmark), Eli Lilly (U.S),SanofiAventis(France),B
    iocon (India), Julphar(U.A.E),Wockhardt
    (India),SemBioSys (Canada), and GSK (U.K.).

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
About PowerShow.com